Evidence map›Paper›PMID 36039057›Full record

ArticleOncology letters2022

S-phase fraction, lymph node status and disease staging as the main prognostic factors to differentiate between young and older patients with invasive breast carcinoma.

António E Pinto, João Matos, Teresa Pereira, Giovani L Silva, Saudade André

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Molecular Biological Determination ofInternational journal of molecular sciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

António E PintoDepartment of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.
João MatosDepartment of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.
Teresa PereiraDepartment of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.
Giovani L SilvaDepartment of Mathematics, Higher Technical Institute, University of Lisbon, 1049-001 Lisbon, Portugal.
Saudade AndréDepartment of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.
Instituto Português de Oncologia Francisco Gentil · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The influence of age on the outcome of patients with invasive breast carcinoma (IBC) has not yet been fully established. The present study investigated two subgroups of patients either side of the age spectrum, and evaluated cytometric, histopathological and molecular characteristics. The series involved 219 patients with IBC that had long-term follow-up, which were divided into two subgroups: Young (≤45 years; n=103) and old patients (≥75 years; n=116). Immunohistochemical evaluation of hormonal receptors, Ki67 index and HER2 status (plus HER2 silver

Indexed as

histopathological featuresinvasive breast carcinomaprognosisproliferative markersyoung and older patients

Identifiers

PMID36039057
PMCPMC9404687
OpenAlexW4289767133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.